1. What is the projected Compound Annual Growth Rate (CAGR) of the Cell Cryopreservation Market?
The projected CAGR is approximately 21.5%.
Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.
Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.
Market
Insights
Reports delivered globally, covering a wide range of industries and sectors.
Clients who trust our expertise and rely on our insights for business decisions.
Managed Reports, ensuring seamless updates and premium service.
Satisfied Customers, committed to delivering exceptional value and quality.
Cell Cryopreservation Market by The market by product type is categorized into cryoprotectant agents and equipment. The equipment into garnered USD 7.5 billion revenue size in the year 2023. The equipment segment is further segmented freezers, incubators, liquid nitrogen supply tanks and cryopreservation consumables. Concurrently, there is a notable trend towards automation in cryopreservation equipment. (Automated systems are gaining prominence for their ability to streamline workflows, minimize manual errors, and significantly enhance the overall efficiency of processes related to cell banking and storage., As a result, there is a rising demand for cryopreservation equipment equipped with integrated automation features. This shift underscores the industry's commitment to adopting cutting-edge technologies that not only meet the demands of biobanking but also contribute to the advancement of cryopreservation practices., The rise in biobanking activities, driven by increased demand for high-quality biological samples, directly impacts the demand for biomedical refrigerators and freezers. Biobanks utilize specialized equipment for the preservation and storage of diverse biological materials.), by Product Type, 2018 – 2032 (USD Million) (Cryoprotectant agents, Equipment), by Cell Type, 2018 – 2032 (USD Million) (Stem cells, Oocytes and embryotic cells, Sperm cells, Hepatocytes, Other cell types), by Application, 2018 – 2032 (USD Million) (Drug discovery and development, Regenerative medicine, Organ transplantation, Clinical research, Other applications), by End-use, 2018 – 2032 (USD Million) (Hospitals and clinics, Biotechnology and pharmaceutical companies, Research and academic institutes, Contract research organizations (CROs)), by North America (U.S., Canada), by Europe (Germany, UK, France, Italy, Spain, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Rest of Latin America), by Middle East & Africa (Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa) Forecast 2025-2033
The global cell cryopreservation market is experiencing robust growth, projected to reach a market size of $10.4 billion in 2023, expanding at a compound annual growth rate (CAGR) of 21.5%. This significant expansion is driven by several key factors. The increasing demand for high-quality biological samples for research and therapeutic applications fuels the growth of biobanks, creating a substantial demand for cryopreservation equipment such as freezers, incubators, and liquid nitrogen tanks. The equipment segment, generating $7.5 billion in revenue in 2023, is a major contributor to market growth, further bolstered by the rising adoption of automated systems. Automation enhances efficiency, reduces errors, and streamlines workflows in cell banking and storage, significantly impacting the market. Furthermore, advancements in cryoprotectant agents are improving cell viability and storage longevity, driving market expansion across diverse applications, including drug discovery, regenerative medicine, and organ transplantation. The market is segmented by product type (cryoprotectant agents and equipment), cell type (stem cells, oocytes, sperm cells, etc.), application (drug discovery, regenerative medicine, etc.), and end-user (hospitals, biotech companies, research institutes, etc.). Geographic growth is observed across regions, with North America and Europe currently holding significant market shares, while Asia Pacific is expected to witness considerable growth due to increasing research and development activities.
The market's future trajectory is shaped by several trends. The ongoing development of novel cryoprotectants with improved efficacy and reduced toxicity will continue to drive demand. Furthermore, the increasing adoption of personalized medicine and advanced therapies, particularly in regenerative medicine and cell-based therapies, will significantly impact market growth. However, potential restraints include the high cost of cryopreservation equipment and the need for specialized training and expertise in handling cryopreserved cells. Nevertheless, the substantial growth potential of the cell cryopreservation market is expected to outweigh these challenges, making it a highly attractive sector for investment and innovation in the coming years. Companies like Thermo Fisher Scientific, Sartorius, and BioLife Solutions are key players shaping the market landscape through technological advancements and strategic partnerships.
The cell cryopreservation market exhibits a moderately concentrated structure, with a few major players holding significant market share. Thermo Fisher Scientific, Sartorius AG, and Merck KGaA are among the leading companies, benefiting from established brand recognition, extensive distribution networks, and diversified product portfolios. However, several smaller, specialized companies also contribute significantly, particularly in niche areas like specialized cryoprotectants or automated systems.
Characteristics of innovation within the market include a strong focus on automated cryopreservation systems, improved cryoprotectant formulations (reducing cell damage), and the development of more efficient and reliable freezing and thawing protocols. The market is also characterized by a rising demand for GMP-compliant products, driven by the growth of cell and gene therapies.
Regulatory impact is substantial, particularly concerning the storage and handling of human cells and tissues, varying by region and application. Stringent regulatory guidelines influence the design, manufacturing, and distribution of cryopreservation equipment and reagents. While direct substitutes for cryopreservation are limited, alternative preservation methods, such as lyophilization, compete in specific niches.
End-user concentration is notable, with significant demand originating from biotechnology and pharmaceutical companies, research institutes, and hospitals & clinics. The level of mergers and acquisitions (M&A) activity within the cell cryopreservation market is moderate, with larger companies strategically acquiring smaller firms to expand their product lines and technological capabilities.
The cell cryopreservation market is experiencing robust growth fueled by several key trends. The burgeoning field of regenerative medicine is a primary driver, with increased demand for high-quality cryopreserved cells for therapies like cell transplantation and tissue engineering. Similarly, advancements in cell and gene therapies are boosting the need for reliable cell preservation methods, facilitating the development and commercialization of these innovative treatments.
The expansion of biobanks is another significant trend. Biobanks store large collections of biological samples for research, clinical trials, and diagnostic purposes, creating a substantial demand for cryopreservation technologies and services. The rise of personalized medicine further contributes to this trend, as tailored treatments require efficient sample storage and retrieval.
Automation is revolutionizing cryopreservation workflows. Automated systems enhance efficiency, reduce the risk of human error, and improve the reproducibility of results. This trend is particularly prevalent in large-scale cell banking operations and pharmaceutical manufacturing. Simultaneously, there's a strong focus on developing improved cryoprotectants that minimize cell damage during freezing and thawing, increasing cell viability post-thaw.
Further driving the market is the increasing adoption of cloud-based platforms for managing and tracking cryopreserved cells, improving data management and accessibility. This trend facilitates collaborative research and simplifies inventory management, benefiting both academic institutions and commercial entities. The global shift towards outsourcing cell banking and storage services to specialized contract research organizations (CROs) further fuels market expansion, as CROs require sophisticated cryopreservation infrastructure to meet the demands of their clients. Finally, ongoing research and development efforts to improve cryopreservation techniques for various cell types, including stem cells, oocytes, and specialized cells, will sustain growth.
North America: This region is currently the dominant market due to the high concentration of research institutions, biotechnology companies, and advanced healthcare infrastructure, along with significant investment in regenerative medicine and cell therapy initiatives. The robust regulatory framework, while stringent, encourages innovation and adoption of cutting-edge technologies. The US, in particular, holds a substantial market share owing to its highly developed biomedical research ecosystem.
Europe: Follows North America as a major market, with several European countries (Germany, UK, France) exhibiting strong growth due to robust pharmaceutical and biotech industries, and a substantial investment in R&D. Stringent regulatory frameworks are in place, but these also stimulate innovation and the development of compliant technologies.
Asia Pacific: The Asia Pacific region is witnessing rapid expansion, driven by increasing healthcare spending, growing awareness of the benefits of cryopreservation technologies, and the increasing presence of multinational companies investing in the region. Significant expansion is forecast driven by the burgeoning pharmaceutical and biotechnology sectors in China, Japan, India, and South Korea.
Dominant Segment: Equipment: The equipment segment, including freezers, automated systems, liquid nitrogen tanks, and cryopreservation consumables, represents the largest segment in the market. The substantial capital expenditure on equipment drives significant revenue generation, surpassing that of cryoprotectant agents. The increasing demand for automated systems, driven by rising efficiency requirements and the need for error reduction, further fuels the dominance of this segment.
This report provides comprehensive insights into the cell cryopreservation market, analyzing market dynamics, key trends, competitive landscape, and future growth prospects. It offers a detailed segmentation by product type (cryoprotectants and equipment), cell type, application, and end-user, providing granular market size and growth projections for each segment. Detailed regional analyses, including market sizing and growth forecasts, will also be presented. The report includes company profiles of leading market players, highlighting their strengths, strategies, and recent developments. Market forecasts extending to 2032 will provide a long-term view for strategic planning.
The global cell cryopreservation market is experiencing substantial growth, projected to reach an estimated $25 billion by 2032, up from approximately $12 billion in 2023. This represents a Compound Annual Growth Rate (CAGR) exceeding 8%. The growth is fueled by expanding applications in regenerative medicine, cell therapy, and biobanking, alongside the technological advancements discussed previously.
The equipment segment holds the largest market share, currently estimated at around 60% of the total market value in 2023 ($7.5 billion). This significant share is due to the high capital expenditure associated with purchasing and maintaining cryopreservation equipment. The cryoprotectant agents segment, while smaller, is expected to exhibit considerable growth due to ongoing innovations in reducing cryoinjury and improving cell viability.
Market share is concentrated among a few key players, with the top five companies holding an estimated 55% of the global market. However, the market is characterized by considerable competition, with smaller, specialized companies gaining traction through product innovation and focused market segments. Future growth is anticipated to be driven by continued technological advancements, the expanding biobanking sector, and the increasing adoption of cell and gene therapies.
The market's growth is fueled by several key factors: the increasing demand for cell-based therapies in regenerative medicine, the rapid expansion of biobanking initiatives globally, technological advancements leading to improved cell viability post-thaw and automated systems, and the growing adoption of personalized medicine requiring efficient sample storage.
Challenges include the high cost of cryopreservation equipment and consumables, stringent regulatory requirements, and the risk of cell damage during freezing and thawing. Competition from alternative preservation methods and the need for skilled personnel to operate complex cryopreservation systems also present obstacles.
Emerging trends include the growing adoption of automated cryopreservation systems, the development of improved cryoprotectants minimizing cell damage, and the increasing use of cloud-based platforms for cell tracking and management. Furthermore, the focus on GMP compliance and the expansion of outsourcing to CROs are shaping the market's trajectory.
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 21.5% from 2019-2033 |
Segmentation |
|
Note* : In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 21.5%.
Key companies in the market include Thermo Fisher Scientific Inc., Sartorius AG, PromoCell GmbH, BioLife Solutions Inc., Merck KGaA, HiMedia Laboratories, Creative Biolabs, Corning Incorporated, GE Healthcare, Danaher Corporation.
The market segments include The market by product type is categorized into cryoprotectant agents and equipment. The equipment into garnered USD 7.5 billion revenue size in the year 2023. The equipment segment is further segmented freezers, incubators, liquid nitrogen supply tanks and cryopreservation consumables. Concurrently, there is a notable trend towards automation in cryopreservation equipment., Product Type, 2018 – 2032 (USD Million), Cell Type, 2018 – 2032 (USD Million), Application, 2018 – 2032 (USD Million), End-use, 2018 – 2032 (USD Million).
The market size is estimated to be USD 10.4 Billion as of 2022.
Rising stem cell research. Increasing organ transplantation procedures. Growing trend towards personalized medicine. Increasing biobanking activities.
N/A
High cost of cryopreservation technologies. Ethical and regulatory challenges.
In July 2023, PromoCell, a manufacturer of cell culture products, announced the launch of PromoExQ MSC Growth Medium XF. This serum- and xeno-free cell culture medium was specifically designed to adhere to good manufacturing practice (GMP) standards, facilitating compliant maintenance, and enabling the long-term expansion of mesenchymal stem cells (MSC). This targeted product enabled the company to cater to a broader customer base, including researchers and companies involved in stem cell research, regenerative medicine, and cell therapy.
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4,850, USD 5,350, and USD 8,350 respectively.
The market size is provided in terms of value, measured in Billion.
Yes, the market keyword associated with the report is "Cell Cryopreservation Market," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Cell Cryopreservation Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.